Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.37 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 6/20 | 0.34 |
| ▸ | TDP2 | O95551 | 2/20 | 0.34 |
| ▸ | CTSD | P07339 | 2/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23318634 | 0.97 | HSD11B1 (0.38) | PDK2HSD11B1CXCR3PGRTDP2 | |
| SCHEMBL23609590 | 0.91 | TDP2 (0.39) | PDK2HSD11B1CXCR3PGRTDP2 | |
| SCHEMBL23609589 | 0.91 | PDK2 (0.43) | PDK2HSD11B1CXCR3PGRTDP2 | |
| SCHEMBL23609927 | 0.91 | HSD11B1 (0.39) | PDK2HSD11B1CXCR3PGRTDP2 | |
| SCHEMBL23609300 | 0.90 | PDK2 (0.35) | PDK2HSD11B1BACE1 | |
| SCHEMBL24406024 | 0.87 | CXCR3 (0.36) | PDK2HSD11B1CXCR3PGRTDP2 | |
| SCHEMBL23609842 | 0.86 | HSD11B1 (0.36) | PDK2HSD11B1CXCR3PGRTDP2 | |
| SCHEMBL23614377 | 0.86 | PDK2 (0.45) | PDK2HSD11B1CXCR3PGRTDP2 | |
| SCHEMBL25452143 | 0.86 | PDK2 (0.42) | PDK2HSD11B1CXCR3PGRTDP2 | |
| SCHEMBL25962015 | 0.85 | SLC6A3 (0.38) | PDK2HSD11B1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3826080-B1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MAT CO LTD (CN) | 2022-05-11 | — | — | EP | disclosed |
| EP-3826080-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | Shaanxi Lighte Optoelectronics Material Co., Ltd. (CN) | 2021-05-26 | — | — | EP | disclosed |
| US-20210130313-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO. LTD. (CN) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130313-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | EXOC1, NPM1, EXOC4 | PDK2 3410/4885HSD11B1 4282/4885CXCR3 3484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.